AngioDynamics Names Eric Honroth CEO with $2.3M Signing Package; Clemmer Stays as $30K/Month Consultant
ANGO sits 52% above its 52-week low of $9.39 on elevated volume (2.0× avg).
Summary
AngioDynamics appointed Eric Honroth as President and CEO effective November 2, 2026, with a $735K base salary, $350K sign-on bonus, and $1.9M in equity awards. Outgoing CEO Jim Clemmer will consult at $30K/month for up to one year, and the board approved retention agreements for the full executive team.
Key Events · Executive and Board Changes · ANGO
-
New CEO Appointed
Eric Honroth, formerly President Life Science at Getinge AB, has been appointed President and CEO effective November 2, 2026, succeeding Jim Clemmer, who retires after ten years.
-
CEO Compensation Package
Honroth's compensation includes a $735,000 base salary, 95% target bonus, $350,000 cash sign-on bonus, $450,000 equity buy-out RSUs, and a $1,487,116 initial inducement award (350% of base salary prorated), plus a $10,000 monthly commuting allowance for 24 months.
-
Clemmer Consulting Agreement
Outgoing CEO Jim Clemmer will provide consulting services for up to one year at $30,000 per month, with a lump-sum payout if the agreement is terminated early.
-
Executive Retention Agreements
The board approved equity retention agreements for the entire executive leadership team (excluding Clemmer), providing accelerated vesting of RSUs and pro-rata PSU vesting if terminated without cause within 12 months of the new CEO's start.
Analysis · ANGO · Industrial Applications And Services
The CEO transition at AngioDynamics is now formalized, with Eric Honroth taking the helm on November 2, 2026, under a compensation package valued at roughly $2.3 million in first-year cash and equity. The 8-K also discloses retention agreements covering the entire executive leadership team and the retirement of long-serving director Howard Donnelly. The breadth of these retention incentives signals that the board is actively locking down its leadership bench during the transition, while Clemmer's consulting agreement ensures continuity through the first year.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.8% of the 1732 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ANGO was trading at $14.26 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $596.8M. The 52-week trading range was $9.39 to $16.29. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.